Shengyuan Xu

Title: Innovations of Shengyuan Xu in Protein Research

Introduction

Shengyuan Xu is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of protein research, particularly in the study of phospholipase B proteins. With a total of 2 patents, his work has implications for both scientific research and potential medical applications.

Latest Patents

Shengyuan Xu's latest patents focus on methods for determining the occurrence or level of a mammalian protein in a sample. One patent describes methods for assessing the capability of a compound to transform or inhibit the transformation of a selected mammalian protein in its pro-phospholipase B form to an enzyme-active phospholipase B form. This involves the use of a pro-phospholipase B (PLB-II) mammalian protein that includes at least one SU2 subunit with a specific molecular weight. Another patent details a novel mammalian protein related to the human hypothetical protein FLJ22662, which is expressed in neutrophils and characterized as a phospholipase B of a new family (PLB-II). This protein comprises one or two single-chain polypeptide SU subunits that differ in their amino acid sequences.

Career Highlights

Throughout his career, Shengyuan Xu has worked with various companies, including P&M Venge AB and Future Medical Diagnostics Co., Ltd. His expertise in protein research has positioned him as a valuable contributor to the scientific community.

Collaborations

Shengyuan Xu has collaborated with notable individuals in his field, including Per Venge and Venge Per. These collaborations have likely enhanced his research and contributed to his innovative work.

Conclusion

Shengyuan Xu's contributions to protein research through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in understanding mammalian proteins and their applications.